BioCentury | Sep 16, 2013
Company News

Buderer Drug, Imprimis deal

...Buderer and received a right of first refusal for additional IP (see BioCentury, June 24). Buderer Drug Co....
BioCentury | Jun 24, 2013
Company News

Imprimis, Buderer Drug deal

...using PCCA's drug formulations and drug delivery technologies. Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY), San Diego, Calif. Buderer Drug Co....
Items per page:
1 - 2 of 2
BioCentury | Sep 16, 2013
Company News

Buderer Drug, Imprimis deal

...Buderer and received a right of first refusal for additional IP (see BioCentury, June 24). Buderer Drug Co....
BioCentury | Jun 24, 2013
Company News

Imprimis, Buderer Drug deal

...using PCCA's drug formulations and drug delivery technologies. Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY), San Diego, Calif. Buderer Drug Co....
Items per page:
1 - 2 of 2